Bull Harbor Capital »

Allogene Therapeutics shares owned by Bull Harbor Capital

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Bull Harbor Capital from 13F filings

Historical chart of Bull Harbor Capital investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Bull Harbor Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Bull Harbor Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $31k 13k 2.44

More positions owned by Bull Harbor Capital

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Ft Vest U.s Eqt (GMAR)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Amazon (AMZN)
Comfort Systems USA (FIX)
Bristol Myers Squibb (BMY)
Broadcom (AVGO)
Edison International (EIX)
Wal-Mart Stores (WMT)
Micron Technology (MU)
PG&E Corporation (PCG)
Bank of America Corporation (BAC)

View all positions for Bull Harbor Capital

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Millennium Management
Candriam Luxembourg S.C.A.
Wildcat Capital Management

View all funds holding Allogene Therapeutics